China Pharma Holding Inc logo

China Pharma Holding Inc

$ 0.14 +0.0002 (+0.14%) 10:23 AM EST
P/E:
At Loss
P/B:
1.69
Market Cap:
$ 6.98M
Enterprise V:
$ 15.34M
Volume:
10.85K
Avg Vol (2M):
291.70K
Also Trade In:
Volume:
10.85K
Market Cap $:
6.98M
PE Ratio:
At Loss
Avg Vol (2-Month):
291.70K
Enterprise Value $:
15.34M
PB Ratio:
1.69
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
Name Current Vs Industry Vs History
Cash-To-Debt 0.21
Equity-to-Asset 0.23
Debt-to-Equity 2.63
Debt-to-EBITDA -1174.22
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.63
Distress
Grey
Safe
Beneish M-Score -4.81
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 35.64
9-Day RSI 32.22
14-Day RSI 32.2
6-1 Month Momentum % -50.43
12-1 Month Momentum % -67.47

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.75
Quick Ratio 0.33
Cash Ratio 0.27
Days Inventory 144.9
Days Sales Outstanding 20.82
Days Payable 30.47

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.8

Financials (Next Earnings Date:2022-11-12 Est.)

CPHI's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with AMEX:CPHI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 8.085
EPS (TTM) ($) -0.08
Beta 0.11
Volatility % 43.09
14-Day RSI 32.2
14-Day ATR ($) 0.017558
20-Day SMA ($) 0.167895
12-1 Month Momentum % -67.47
52-Week Range ($) 0.13 - 0.7899
Shares Outstanding (Mil) 50.45

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

China Pharma Holding Inc Filings

Document Form Filing Date
No Filing Data

China Pharma Holding Inc Analysis

Share your research

Headlines

See More
No news.